Jocelyn Kaiser Profile
Jocelyn Kaiser

@jocelynkaiser

Followers
1,333
Following
57
Media
3
Statuses
101

I'm a reporter covering NIH and biomedical research policy for Science magazine.

Joined February 2009
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@jocelynkaiser
Jocelyn Kaiser
9 years
How is replicating a cancer study like baking a cake? See my feature http://t.co/0V2ObFRdaV
3
24
19
@jocelynkaiser
Jocelyn Kaiser
6 years
WOW. Novartis is buying the gene therapy firm AveXis for $8.7 billion. Here's my 2017 story on how their treatment is saving babies with spinal muscular atrophy, a fatal neuromuscular disease.
0
17
15
@jocelynkaiser
Jocelyn Kaiser
8 years
The office that polices research fraud in US-funded biomedical labs is in turmoil. Read our scoop
0
11
13
@jocelynkaiser
Jocelyn Kaiser
5 years
Shutdown over, but a total of 19 NIH study sections delayed because of Federal Register snafu (backround )
Tweet media one
1
16
13
@jocelynkaiser
Jocelyn Kaiser
8 years
Why using CRISPR to repair broken genes in sick people won't be easy
0
12
12
@jocelynkaiser
Jocelyn Kaiser
7 years
Gene therapy delivered into the blood saves kids with a deadly spinal disease. Next: muscle and brain diseases.
0
7
10
@jocelynkaiser
Jocelyn Kaiser
7 years
Shocking, harrowing story of sexual harassment in Antarctica by my colleague @meredithwadman
1
11
10
@jocelynkaiser
Jocelyn Kaiser
4 years
Researchers have homed in on several common genes that may explain why some people become severely ill from covid-19--and that point to possible treatments @kennethbaillie @covid19_hgi
1
4
10
@jocelynkaiser
Jocelyn Kaiser
5 years
@cristenw @HeidiRehm @merrymanlab @skathire @JACCJournals @ACCinTouch @NEJM Hey @ASAPbio_ and other preprint folks: @nejm has finally put its policy in writing (see correction notice here )
0
1
8
@jocelynkaiser
Jocelyn Kaiser
6 years
Huge news today--first FDA-approved gene therapy for an inherited disease. I profiled the couple behind it back in 2009 (with editor @laurahelmuth )
0
9
8
@jocelynkaiser
Jocelyn Kaiser
5 years
NIH says its All of Us health study is on track to recruit 1 million volunteers in 5-6 years. The bigger worry: keeping them from dropping out. #AllofUs , @allofusresearch
1
0
7
@jocelynkaiser
Jocelyn Kaiser
9 years
My story on Obama precision medicine plan: A genetic biobank on 1 million Americans. http://t.co/J7Ls5nzdDu
1
13
6
@jocelynkaiser
Jocelyn Kaiser
9 years
Tweet media one
1
11
5
@jocelynkaiser
Jocelyn Kaiser
2 years
Yesterday in Boston, President Biden spoke of cancer prevention vaccines and blood tests for early cancers. Read more about both here
0
2
5
@jocelynkaiser
Jocelyn Kaiser
6 years
A star gene therapy researcher's's dark history of alleged sexual harassment in the lab is revealed in this meticulously reported story by @meredithwadman
0
4
5
@jocelynkaiser
Jocelyn Kaiser
4 years
Good news for AIDS community: Moderna will no longer exclude HIV positive people from its large covid-19 vaccine study. But that's just one company's trial.
@moderna_tx
Moderna
4 years
Today, we are sharing an important update about our protocol for the Phase 3 COVE Study of mRNA-1273, our vaccine candidate against COVID-19.
Tweet media one
27
107
375
0
1
4
@jocelynkaiser
Jocelyn Kaiser
6 years
At Senate hearing, @NIHDirector just announced that NIH has suspended enrollment in controversial study of moderate alcohol consumption pending investigation. background:
0
8
4
@jocelynkaiser
Jocelyn Kaiser
9 years
My story on the odd tale of a woman whose fractured chromosome cured her disease. http://t.co/Mn0Q4NeBh0
0
3
4
@jocelynkaiser
Jocelyn Kaiser
7 years
More than 1400 have signed petition protesting NIH plan to classify basic brain studies as clinical trials
0
2
4
@jocelynkaiser
Jocelyn Kaiser
4 years
Because of COVID-19, NIH is urging that all large meeting held at NIH or organized by NIH be held virtually by video or postponed or cancelled. That includes study sections, as first reported by @MedResJourno
0
11
4
@jocelynkaiser
Jocelyn Kaiser
7 years
Scientists and now university groups protest new NIH clinical trials definition Background:
0
5
2
@jocelynkaiser
Jocelyn Kaiser
1 year
Stops in September 2022
@CWolinetzNIH
Carrie D. Wolinetz
1 year
@jocelynkaiser @NIH Like this, for example:
0
0
2
2
0
3
@jocelynkaiser
Jocelyn Kaiser
7 years
Personalized cancer vaccines may help keep melanoma in check and shrink tumors in combo with checkpoint inhibitor.
0
0
4
@jocelynkaiser
Jocelyn Kaiser
4 years
Just before covid stopped travel, I met with Costa Rica's rising stars in tropical biology who are coming home to study their country's rich biodiversity. @AndreaGVincent   #UCR   @ICFJKnight   @PuntoyAparte_1   #ICFJ @ICFJ #UCR
1
1
4
@jocelynkaiser
Jocelyn Kaiser
7 years
I went to Riyadh to learn how Saudi geneticists are striving to prevent rare diseases in their country. My story:
0
1
3
@jocelynkaiser
Jocelyn Kaiser
2 years
@giovannidalloli
giovanni dall'olio 🇮🇹🇪🇺🇺🇦
2 years
Spurred by pandemic, U.S. government will revisit federal policies on risky virus research
0
0
1
0
1
2
@jocelynkaiser
Jocelyn Kaiser
7 years
Tom Price, HHS nominee, says he will support science, "make sure factual information is conveyed"
0
1
3
@jocelynkaiser
Jocelyn Kaiser
9 years
Watching webcast: Risks and Benefits of Gain-of-Function Research: A Symposium: http://t.co/p6urtCvTr0
1
1
3
@jocelynkaiser
Jocelyn Kaiser
7 years
Thanks to @jorisveltman and @dgmacarthur for their help with my story on human genetics in Saudi Arabia
1
1
3
@jocelynkaiser
Jocelyn Kaiser
5 years
Does it matter that 19% of sample so far is from Arizona (2% of US pop) and 59% are women? #AllOfUS
@maggieeastfire
Maggie Westwater, PhD
5 years
#allofus is also well-positioned to examine whether differences in health outcomes reflect variable pathogenesis of disease X by group, or if they are largely driven by failings of the health care system in these communities. The policy implications of this would be massive.
0
0
0
0
0
3
@jocelynkaiser
Jocelyn Kaiser
7 years
HHS Sec Price confirms at House hearing that indirect costs are target of Trump NIH budget: "about 30% of grant money" goes to indirects
2
7
3
@jocelynkaiser
Jocelyn Kaiser
9 years
Harold Varmus on his time at NCI and why he's going back to the lab. http://t.co/jgXepDygNN
2
1
3
@jocelynkaiser
Jocelyn Kaiser
9 years
Good news for MERS researchers: NIH exempts animal model work from pause on risky virology studies http://t.co/ZHIrFdUA3C #GOF , #MERS
0
2
3
@jocelynkaiser
Jocelyn Kaiser
6 years
Yes it may be. More on study here. and here
@antonioregalado
Antonio Regalado
6 years
Far as I know this if the first large-scale implementation of a "liquid biopsy" screening test that looks for *many* cancers at once.
0
27
46
1
0
3
@jocelynkaiser
Jocelyn Kaiser
7 years
An NIH question! Price says he supports efforts to boost funding for Alzheimer's research.
0
3
2
@jocelynkaiser
Jocelyn Kaiser
9 years
Yesterday's #NSABB meeting: Last October's 1-year "pause" on risky virology studies will now last ~21 months.
0
2
2
@jocelynkaiser
Jocelyn Kaiser
6 years
@katewbauer @JasonSynaptic @thebyrdlab @Maratosflier From my notes from the June 2018 ACD meeting, NIH is hoping to get to 1100 ESIs this year, up from 1040 in 2017 (so not a huge increase)
0
1
2
@jocelynkaiser
Jocelyn Kaiser
9 years
Obama's $1B raise for NIH in 2016 boosts BRAIN initiative, Alzheimer's, vaccines, precision med, antibiotics @ScienceInsider
0
2
2
@jocelynkaiser
Jocelyn Kaiser
9 years
"The horror case," says Fineberg: high path, transmissibility in mammals, evasion to countermeasures. Subarrao says regs restrict.
0
1
2
@jocelynkaiser
Jocelyn Kaiser
6 years
Two new studies from Reproducibility Project: Cancer Biology reproduced some, but not all original results. 9 (of 29) now out, just 4 fully replicated. background:
0
0
2
@jocelynkaiser
Jocelyn Kaiser
9 years
@martinenserink yes, one newsy tidbit: USG decision on paused studies put off to mid 2016 #NSABB
0
5
2
@jocelynkaiser
Jocelyn Kaiser
1 year
Monthly FOIA logs--what a concept! How I wish @NIH did this
@CWolinetzNIH
Carrie D. Wolinetz
1 year
Things I enjoyed about this Tweet (in no particular order): 1) Wonky reg humor = comic gold; 2) I <3 students using mechanisms of govt transparency; 3) I enjoy discovering new (to me) public universities like @letsgopeay ; 4) I have an excuse to hum @SpongeBob theme
1
0
2
2
0
2
@jocelynkaiser
Jocelyn Kaiser
7 years
Senate subcommittee approves $2B increase for NIH in 2018. Details to come.
0
2
1
@jocelynkaiser
Jocelyn Kaiser
5 years
NIH has corrected earlier figure--only 16 meetings rescheduled. NIDCD meetings did or will occur on schedule.
@jocelynkaiser
Jocelyn Kaiser
5 years
Shutdown over, but a total of 19 NIH study sections delayed because of Federal Register snafu (backround )
Tweet media one
1
16
13
0
1
2
@jocelynkaiser
Jocelyn Kaiser
4 years
Just back from a fantastic week in Costa Rica with @ICFJKnight journalism exchange. Many thanks to my excellent host, Silvia from @PuntoyAparte_1 , and to the many journalists and scientists who met with me. #ICFJ @ICFJ #UCR #UNA #ITCR #SINAC
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
2
@jocelynkaiser
Jocelyn Kaiser
5 years
Saw that study finding men get $40,000 more for their first NIH grant? We took a closer look.
0
0
0
@jocelynkaiser
Jocelyn Kaiser
10 years
A glut of US biomedical phds, but too few physician scientists? http://t.co/Urww28bF1O
1
0
1
@jocelynkaiser
Jocelyn Kaiser
9 years
Puzzled by slamming of NIH award for oldsters to wind down labs. Isn't idea to make room for young? http://t.co/VYEBzAMX1c #emeritusNIHGrant
3
3
1
@jocelynkaiser
Jocelyn Kaiser
9 years
NIAID's Kana Subbarao makes plea to lift funding pause for rodent studies and MERS, flu strains that emerged in 2014
0
1
1
@jocelynkaiser
Jocelyn Kaiser
7 years
Price: evidence clear that HIV causes aids, abortions do not cause breast cancer. unfamiliar with claim that immigrants spread leprosy
0
1
1
@jocelynkaiser
Jocelyn Kaiser
5 years
0
0
1
@jocelynkaiser
Jocelyn Kaiser
7 years
As expected, Trump 2018 budget plan slashes NIH overhead payments (indirect costs) to 10% (from current 30% avg)
2
0
1
@jocelynkaiser
Jocelyn Kaiser
6 years
Doesn't sound too drastic
@jeanniereporter
Jeannie Baumann
6 years
Does anyone know exactly what "Restructure NIH’s administrative functions to ensure operations are effective and efficient" means in terms of what will happen?
0
0
0
1
0
1
@jocelynkaiser
Jocelyn Kaiser
9 years
Subbarao, Michael Imperiale: Need more precise term than "gain of function," which is too broad, covers routine virology studies
0
1
1
@jocelynkaiser
Jocelyn Kaiser
3 years
@NewsfromScience
News from Science
3 years
Scientists question the usefulness and validation of a saliva-based genetic test for #COVID19 severity now sold in the United States.
0
4
6
0
0
1
@jocelynkaiser
Jocelyn Kaiser
7 years
That's right--corresponding authors are what bioRxiv gave us. But if you look at coauthors the list would be different--eg 50 for @dalygene
@blekhman
Ran Blekhman
7 years
@ClausWilke @EricTopol @jocelynkaiser @erlichya I think the article refers to most preprints as corresponding author
1
0
0
0
0
1
@jocelynkaiser
Jocelyn Kaiser
9 years
Flu projects in limbo while NIH decides which must stop under gain of function moratorium. See the letters here. http://t.co/qzbw3YVWM1
0
3
1
@jocelynkaiser
Jocelyn Kaiser
10 years
Top U.S. Scientific Misconduct Official Quits in Frustration With Bureaucracy http://t.co/Ih1ntQtB7y
0
1
1
@jocelynkaiser
Jocelyn Kaiser
7 years
...more Price: and vaccines do not cause autism.
0
1
1
@jocelynkaiser
Jocelyn Kaiser
7 years
It was a delight to meet Evelyn, saved by gene therapy from the disease that took her big sister.
0
1
1
@jocelynkaiser
Jocelyn Kaiser
7 years
Yes, NIH says they'll look at intramural too
@surgeonretina
Rajesh Rao, MD
7 years
. @jocelynkaiser Will grant limits affect @IRPatNIH vs @NIHgrants PIs equally? 50% intramural PIs have >$1.2M, yet < 6% extramural PI do.
1
0
0
1
1
1